-
Jefferies Raises PT On St. Jude Medical
Tuesday, January 18, 2011 - 8:52am | 28Jefferies & Company has raised the price target on St. Jude Medical (NYSE: STJ) from $46 to $49 and maintains its Buy rating.
-
Jefferies Raises PT On St. Jude Medical
Tuesday, January 18, 2011 - 8:52am | 28Jefferies & Company has raised the price target on St. Jude Medical (NYSE: STJ) from $46 to $49 and maintains its Buy rating.
-
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin (TRIB, AXK, BLUD, VIVO)
Tuesday, January 18, 2011 - 4:22am | 128Below are the top small-cap diagnostic substance stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 59.32%. TRIB's PEG ratio is 1.60. The trailing-twelve-month profit margin at Accelr8 Technology...
-
Covidien Backs FDA on Acetaminophen - Analyst Blog
Monday, January 17, 2011 - 6:01pm | 628Ireland-based healthcare product maker Covidien plc (COV) has backed the U.S. Food and Drug Administration's (FDA) recent move on the safe use of acetaminophen, a drug used to relieve pain and lower fever. The FDA recently requested manufacturers to restrict the use of acetaminophen in pain...
-
St Jude's New Ultrasound System - Analyst Blog
Monday, January 17, 2011 - 5:31pm | 646Medical devices giant St. Jude Medical (STJ) has introduced the ViewMate Z intracardiac ultrasound system and the ViewFlex Plus Intracardiac Echocardiography (“ICE”) catheter. ViewMate Z is used for real-time image guidance and visualization of a patient's cardiac anatomy and is capable of...
-
Covidien Backs FDA on Acetaminophen - Analyst Blog
Monday, January 17, 2011 - 5:30pm | 628Ireland-based healthcare product maker Covidien plc (COV) has backed the U.S. Food and Drug Administration's (FDA) recent move on the safe use of acetaminophen, a drug used to relieve pain and lower fever. The FDA recently requested manufacturers to restrict the use of acetaminophen in pain...
-
St Jude's New Ultrasound System - Analyst Blog
Monday, January 17, 2011 - 5:15pm | 646Medical devices giant St. Jude Medical (STJ) has introduced the ViewMate Z intracardiac ultrasound system and the ViewFlex Plus Intracardiac Echocardiography (“ICE”) catheter. ViewMate Z is used for real-time image guidance and visualization of a patient's cardiac anatomy and is capable of...
-
Syneron Bags FDA Clearance - Analyst Blog
Monday, January 17, 2011 - 1:01pm | 491Syneron Medical Ltd. (ELOS), a worldwide aesthetic products company, recently announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) to market its latest Tanda Light Emitting Diode (“LED”) to be utilized for skin rejuvenation. The new skin...
-
Syneron Bags FDA Clearance - Analyst Blog
Monday, January 17, 2011 - 12:30pm | 491Syneron Medical Ltd. (ELOS), a worldwide aesthetic products company, recently announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) to market its latest Tanda Light Emitting Diode (“LED”) to be utilized for skin rejuvenation. The new skin...
-
MDT, Ardian Target Hypertension - Analyst Blog
Friday, January 14, 2011 - 8:01pm | 407Leading medical devices player, Medtronic (MDT) has completed the acquisition of privately-held Ardian for an upfront payment of $800 million. Additionally, Medtronic is liable to pay milestone payments based on Ardian's revenues through 2015. Earlier, in November, the company announced its...
-
MDT, Ardian Target Hypertension - Analyst Blog
Friday, January 14, 2011 - 7:20pm | 407Leading medical devices player, Medtronic (MDT) has completed the acquisition of privately-held Ardian for an upfront payment of $800 million. Additionally, Medtronic is liable to pay milestone payments based on Ardian's revenues through 2015. Earlier, in November, the company announced its...
-
BEST STOCK PICKS FOR 2011
Friday, January 14, 2011 - 2:15pm | 336I don't generally promote stock picking on the site and I certainly don't promote analyst's picks, however, Raymond James has created an interesting process within the firm over the years and their results speak for themselves. Over the last 10 years the annual analyst's picks have generated a 12....
-
Rising Tide Ups TRIB Price Target - Analyst Blog
Friday, January 14, 2011 - 2:01pm | 1041Brian Marckx Rising Tide Ups TRIB Price Target Outlook With the clinical lab coagulation divestiture completed, Trinity Biotech (TRIB) has shifted their energies towards growing the POC platform, with particular focus on infectious disease, HbA1c and coagulation, all of which have...
-
Rising Tide Ups TRIB Price Target - Analyst Blog
Friday, January 14, 2011 - 1:23pm | 1041Brian Marckx Rising Tide Ups TRIB Price Target Outlook With the clinical lab coagulation divestiture completed, Trinity Biotech (TRIB) has shifted their energies towards growing the POC platform, with particular focus on infectious disease, HbA1c and coagulation, all of which have...
-
Good News for Cumberland Pharma - Analyst Blog
Friday, January 14, 2011 - 12:31pm | 539Recently, Cumberland Pharmaceuticals Inc. (CPIX) received a boost when the US Food and Drug Administration (FDA) cleared a new formulation of the company's liver drug Acetadote. The injectable drug has been approved to counteract overdoses of acetaminophen and finds application in hospitals for...